These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18271928)

  • 21. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.
    Vockerodt M; Morgan SL; Kuo M; Wei W; Chukwuma MB; Arrand JR; Kube D; Gordon J; Young LS; Woodman CB; Murray PG
    J Pathol; 2008 Sep; 216(1):83-92. PubMed ID: 18566961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus (EBV)-associated lymphoproliferations in severe combined immunodeficient mice transplanted with Hodgkin's disease lymph nodes: implications of EBV-positive bystander B lymphocytes rather than EBV-infected Reed-Sternberg cells.
    Meggetto F; Muller C; Henry S; Selves J; Mariamé B; Brousset P; Saati TA; Delsol G
    Blood; 1996 Mar; 87(6):2435-42. PubMed ID: 8630408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
    Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
    J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes.
    Faumont N; Chanut A; Benard A; Cogne N; Delsol G; Feuillard J; Meggetto F
    Haematologica; 2009 Mar; 94(3):355-63. PubMed ID: 19211641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6.
    Williams TC; Jackson DJ; Maltby S; Walton RP; Ching YM; Glanville N; Singanayagam A; Brewins JJ; Clarke D; Hirsman AG; Loo SL; Wei L; Beale JE; Casolari P; Caramori G; Papi A; Belvisi M; Wark PAB; Johnston SL; Edwards MR; Bartlett NW
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):344-356. PubMed ID: 33264064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
    Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
    J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Functional analysis of Epstein-Barr virus latent membrane proteins (LMP1) in patients with limphoproliferative disorders].
    Smirnova KV; Diduk SV; Gurtsevich VÉ
    Biomed Khim; 2011; 57(1):114-26. PubMed ID: 21516783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin's disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states.
    Tinguely M; Vonlanthen R; Müller E; Dommann-Scherrer CC; Schneider J; Laissue JA; Borisch B
    Mod Pathol; 1998 Apr; 11(4):307-12. PubMed ID: 9578079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.
    Rawal S; Chu F; Zhang M; Park HJ; Nattamai D; Kannan S; Sharma R; Delgado D; Chou T; Lin HY; Baladandayuthapani V; Luong A; Vega F; Fowler N; Dong C; Davis RE; Neelapu SS
    J Immunol; 2013 Jun; 190(12):6681-93. PubMed ID: 23686488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.
    Quintanilla-Martinez L; Fend F; Moguel LR; Spilove L; Beaty MW; Kingma DW; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Oct; 23(10):1233-40. PubMed ID: 10524524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.
    Satou A; Tabata T; Suzuki Y; Sato Y; Tahara I; Mochizuki K; Oishi N; Takahara T; Yoshino T; Tsuzuki T; Nakamura S
    Virchows Arch; 2021 May; 478(5):969-976. PubMed ID: 33169195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival.
    Huang YC; Lin SJ; Lin KM; Chou YC; Lin CW; Yu SC; Chen CL; Shen TL; Chen CK; Lu J; Chen MR; Tsai CH
    Blood; 2016 Sep; 128(12):1578-89. PubMed ID: 27338098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
    Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
    Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
    Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
    J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
    Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
    Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids.
    Pranzatelli MR; Tate ED; McGee NR; Colliver JA; Ransohoff RM
    J Clin Immunol; 2013 May; 33(4):817-25. PubMed ID: 23340773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.